StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report released on Thursday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of CO opened at $2.99 on Thursday. The stock has a market capitalization of $363.44 million, a price-to-earnings ratio of 4.67 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The business’s 50 day simple moving average is $1.20 and its 200-day simple moving average is $1.34.
Global Cord Blood Company Profile
Featured Articles
- Five stocks we like better than Global Cord Blood
- Investing in large cap stocks: Diving into big caps
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Retail Stocks Investing, Explained
- Why Call Options Volume for These 2 Stocks Spiked Together
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.